Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...

A research team has developed an innovative nanomotor-based strategy to improve immunotherapy for bladder cancer. The study, published in the journal Nature Communications, offers a promising ...

Gene's lead asset shows high complete response rates in BCG-unresponsive NMIBC patients. Click here to read why ENGN stock is a Buy.

All told, from fires and dust storms, from crashing ocean waves and hurricanes, a trillion trillion bacteria cells are emitted into the air each year—a mass of more than 100,000 tons. Close to the ...

The best probiotics contain clinically-backed strains to support gut health. Nutrition experts explain what to look for when deciding on a supplement that's right for you.

Otulfi in a 45 mg/0.5 mL single-dose vial for subcutaneous injection is expected ... environmental mycobacteria), Salmonella ...

Even as climate and committed farmers help AZ rank high for cotton, organic markets, seed production and tech innovation ...

Garcia-del-Muro and colleagues launched IMMUNOPRESERVE, a phase II, multicenter, single-arm ... previously received immunotherapy (other than Bacillus Calmette-Guérin [BCG]) or radiotherapy ...

He and his colleagues launched IMMUNOPRESERVE, a phase II, multicenter, single-arm, open-label clinical ... received immunotherapy (other than Bacillus Calmette-Guérin [BCG]) or radiotherapy ...